GlassScriptPhysician profile
Monique E Kademian
NPI 1477767846
$529.39
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2021: $123 · 2022: $184 · 2023: $22.26 · 2024: $22.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $306.97 | 2021-2022 | |
| Lilly USA, LLC | $40.67 | 2019 | |
| Revance Therapeutics, INC. | $22.29 | 2024 | Daxxify |
| Abbvie INC. | $22.26 | 2023 | |
| Prugen, INC. Pharmaceuticals | $20.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.87 | 2019 | |
| Biofrontera INC. | $19.73 | 2019 | |
| Dermira, INC. | $17.78 | 2019 | |
| Aclaris Therapeutics, INC. | $15.76 | 2019 | |
| Mayne Pharma Commercial LLC | $15.25 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.19 | 2019 | |
| Epi Health, LLC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Kademian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.